Exclusive-HIV patient testing falls in South Africa after US aid cuts, data shows
JOHANNESBURG (Reuters) -Testing and monitoring of HIV patients across South Africa have fallen since the United States cut aid that funded health workers and clinics, with pregnant women, infants and youth the most affected, previously unpublished government data shows.
South Africa has the world's highest burden of HIV, with about 8 million people - one in five adults - living with the virus. The United States was funding 17% of the country's HIV budget until President Donald Trump slashed aid early this year.
Data from the National Health Laboratory Service, a government entity, showed that viral load testing fell by up to 21% among key groups in the last two months, which four HIV experts said appeared to be due to the loss of U.S. funding.
Viral load testing measures how much virus is in the blood of people living with HIV who are on anti-retroviral treatment. It is normally done at least once a year.
It checks whether the treatment is working and whether the virus is sufficiently suppressed to prevent it spreading to others.
With less testing, fewer people who may transmit the virus will be identified. Missing a test can also indicate that a patient has dropped out of the system and may be missing treatment.
It is especially important for pregnant women who may be at risk of transmitting HIV through childbirth, and for infants who need to be diagnosed and treated early to survive.
Trump froze many foreign aid programmes early in his presidency, before reinstating some lifesaving assistance, including parts of the United States President's Emergency Plan for AIDS Relief (PEPFAR), its global HIV initiative. But South Africa was also specifically targeted, with an executive order cutting all funding to the country in February.
South Africa did not rely on U.S. funding for its HIV drugs, but about 15,000 health workers' salaries were paid by PEPFAR, which previously gave South Africa over $400 million a year. Most of that funding has been withdrawn, though it is unclear exactly how much.
The health workers did HIV testing and counselling in districts with a high prevalence of HIV, and followed up when patients missed a check-up or dropped off treatment, which is common.
The PEPFAR funding also supported NGO-run clinics which have now closed. The government has urged HIV patients who did check-ups at those clinics to go to public health centres instead, but public health centres often have long lines and staff can be unwelcoming to certain groups like sex workers or gay men.
'SHOCKING FIGURES'
According to the data seen by Reuters, the number of viral load tests conducted for people aged 15-24 fell by 17.2% in April compared to April last year, after dropping 7.8% year-on-year in March. Total population testing was down 11.4% in April.
Maternal viral load testing was down 21.3% in April after falling by 9.1% in March, and early infant diagnostic testing was down 19.9% in April after falling by 12.4% in March, the same data showed.
The percentage of people who were virally suppressed among those tested also fell nationwide by 3.4% in March and 0.2% in April, with steeper declines for young adults, a further sign that patients may have had their treatment interrupted, the data showed.
The data has not been made public.
"These are shocking figures, with profound implications for maternal and child health across the country," said Francois Venter, executive director of the Ezintsha Research Centre in Johannesburg.
Given a summary of the data, Foster Mohale, a spokesperson for South Africa's Department of Health, said more analysis was needed and that South Africa already had challenges with patient retention and viral load testing before the aid cuts.
But HIV experts have said for months that the health ministry was downplaying the impact of the funding loss in South Africa, and that a drop in testing figures might be an early warning sign - followed by a rise in new cases and deaths.
The U.S. State Department did not immediately respond to a request for comment.
"This data demonstrates what previous models have shown regarding the impact of PEPFAR/USAID cuts on pregnant women and their infants," said Dvora Joseph Davey, an epidemiologist working on maternal and infant HIV at the University of Cape Town.
She said the impact was clear at five public health clinics where she works in Cape Town, which since the U.S. aid cuts have been under-staffed, with fewer nurses to draw blood which is needed for viral load tests.
'GOING TO DIE'
HIV experts said that diagnostic testing was likely impacted by the funding cuts too, though that data was not available.
The counsellors who used to do rapid diagnostic HIV tests are also gone, and pregnant women are no longer being put on preventative HIV drugs (PrEP) because the counsellors are the ones who used to offer that, Davey said.
In the Johannesburg township of Diepsloot, HIV activist and community leader Sophy Moatshe said it was hard to get HIV patients to seek care because of the stigma, and that without health workers reaching out when they miss an appointment, many fall through the cracks.
"These people, they don't want to go to the clinic," she said outside a community centre in the crowded informal settlement. "If there is nobody to check them, they're going to die."
The long-term future of HIV-related U.S. assistance remains uncertain in South Africa and globally, as Trump pursues significant cuts to the international aid budget in line with his "America First" agenda.
The cuts have also hit research, including HIV vaccine trials.
Department of Health spokesperson Mohale said the government was speaking to prospective local and international donors about covering funding gaps, but declined to give details.
The data on testing in April, however, was "a good indication of what's going to happen in the future," said Davey.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
an hour ago
- CNN
US patients can now get Ozempic for half price if they can pay cash
Novo Nordisk announced Monday that US patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don't go through insurance. The move comes as President Donald Trump is pressuring drugmakers to lower drug costs, which have long been a major health care headache for Americans. He and lawmakers have called out popular but pricey GLP-1 drugs, which are used for diabetes and weight loss, noting they are much more expensive in the United States than in other countries. Trump has also been pushing pharmaceutical manufacturers to provide medications directly to consumers at a lower price, cutting out insurers and other players. Novo Nordisk is making Ozempic, which carries a list price of just under $1,000 per month, available at its NovoCare Pharmacy, which ships medications directly to cash-paying consumers. The drugmaker earlier this year launched the direct-to-consumer pharmacy, offering Wegovy, its in-demand weight loss drug, for $499 a month. Rival Eli Lilly has also slashed the price of its GLP-1 weight loss drug, Zepbound, for self-pay patients. The discounted Ozempic price is also available on other platforms, including Novo Nordisk's website and through a partnership with GoodRx, which offers discounts on prescriptions at many pharmacies. The offer is open to eligible patients with an Ozempic prescription, the drugmaker said. Insurers are more likely to cover Ozempic for those with diabetes than they are Wegovy, and Novo Nordisk offers discounts for those with coverage. However, Novo Nordisk is looking to broaden Ozempic's availability even further. 'While Ozempic is well covered in the US, let's not forget that there are some patients who pay out-of-pocket for this vital medicine,' Dave Moore, executive vice president, of Novo Nordisk's US operations, said in a statement. 'We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many.' The company noted in its second-quarter earnings call this month that compounding pharmacies, which are allowed to make versions of medications approved by the US Food and Drug Administration when drugs are in shortage, have affected the sales of its GLP-1 medications. The FDA removed Novo Nordisk's semaglutide-based drugs, Ozempic and Wegovy, along with Eli Lilly's tirzepatide-based drugs, Zepbound and Mounjaro, from the shortage list. Novo Nordisk, however, said compounded versions continue to be sold.


CNN
an hour ago
- CNN
US patients can now get Ozempic for half price if they can pay cash
Prescription drugs Food & healthFacebookTweetLink Follow Novo Nordisk announced Monday that US patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don't go through insurance. The move comes as President Donald Trump is pressuring drugmakers to lower drug costs, which have long been a major health care headache for Americans. He and lawmakers have called out popular but pricey GLP-1 drugs, which are used for diabetes and weight loss, noting they are much more expensive in the United States than in other countries. Trump has also been pushing pharmaceutical manufacturers to provide medications directly to consumers at a lower price, cutting out insurers and other players. Novo Nordisk is making Ozempic, which carries a list price of just under $1,000 per month, available at its NovoCare Pharmacy, which ships medications directly to cash-paying consumers. The drugmaker earlier this year launched the direct-to-consumer pharmacy, offering Wegovy, its in-demand weight loss drug, for $499 a month. Rival Eli Lilly has also slashed the price of its GLP-1 weight loss drug, Zepbound, for self-pay patients. The discounted Ozempic price is also available on other platforms, including Novo Nordisk's website and through a partnership with GoodRx, which offers discounts on prescriptions at many pharmacies. The offer is open to eligible patients with an Ozempic prescription, the drugmaker said. Insurers are more likely to cover Ozempic for those with diabetes than they are Wegovy, and Novo Nordisk offers discounts for those with coverage. However, Novo Nordisk is looking to broaden Ozempic's availability even further. 'While Ozempic is well covered in the US, let's not forget that there are some patients who pay out-of-pocket for this vital medicine,' Dave Moore, executive vice president, of Novo Nordisk's US operations, said in a statement. 'We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many.' The company noted in its second-quarter earnings call this month that compounding pharmacies, which are allowed to make versions of medications approved by the US Food and Drug Administration when drugs are in shortage, have affected the sales of its GLP-1 medications. The FDA removed Novo Nordisk's semaglutide-based drugs, Ozempic and Wegovy, along with Eli Lilly's tirzepatide-based drugs, Zepbound and Mounjaro, from the shortage list. Novo Nordisk, however, said compounded versions continue to be sold.

7 hours ago
The national suicide hotline for LGBTQ+ youth went dead. States are scrambling to help
This is a KFF Health News story. On July 17, the option went dead for LGBTQ+ youth to access specialized mental health support from the national 988 Suicide & Crisis Lifeline. The Substance Abuse and Mental Health Services Administration said a month earlier that it would no longer "silo" services and would instead "focus on serving all help seekers." That meant the elimination of the "Press 3" option, the dedicated line answered by staff specifically trained to handle LGBTQ+ youth facing mental health issues ranging from anxiety to thoughts of suicide. Now, states such as California, Colorado, Illinois and Nevada are scrambling to backfill LGBTQ+ crisis support through training, fees and other initiatives in response to what advocates say is the Trump administration's hostile stance toward this group. In his first day back in the White House, President Donald Trump issued an executive order recognizing only two sexes, male and female, and while campaigning, he condemned gender ideology as "toxic poison." And the administration omitted "T" for transgender and "Q" for queer or questioning in announcing the elimination of the 988 Press 3 option. "Since the election, we've seen a clear increase in young people feeling devalued, erased, uncertain about their future, and seeing resources taken away," said Becca Nordeen, senior vice president of crisis intervention at The Trevor Project, a national suicide prevention and crisis intervention nonprofit for LGBTQ+ youth. Nordeen and other advocates for at-risk kids who helped staff the dedicated line said it has never been more critical for what The Trevor Project estimates are 5.2 million LGBTQ+ people ages 13-24 across the U.S. About 39% of LGBTQ+ young people seriously consider attempting suicide each year, including roughly half of transgender and nonbinary young people, according to a 2023 survey, reflecting a disproportionately high rate of risk. The use of the dedicated line for LGBTQ+ youth had steadily increased, according to data from the federal substance abuse agency, with nearly 1.6 million calls, texts or online chats since its rollout in October 2022, out of approximately 16.7 million contacts to the general line. The Press 3 option reached record monthly highs in May and June. In 2024, contacts to the line peaked in November, the month of the election. Call-takers on the general 988 line do not necessarily have the specialized training that the staff on the Press 3 line had, causing fear among LGBTQ+ advocates that they don't have the right context or language to support youth experiencing crises related to sexuality and gender. If a counselor doesn't know what the concept of coming out is, or being outed, or the increased likelihood of family rejection and how those bring stressors and anxiety, it can inadvertently prevent the trust from being immediately built," said Mark Henson, The Trevor Project's interim vice president of advocacy and government affairs, adding that creating that trust at the beginning of calls was a critical "bridge for a youth in crisis to go forward." The White House's Office of Management and Budget did not immediately respond to questions about why the Press 3 option was shut down, but spokesperson Rachel Cauley told NBC News that the department's budget would not "grant taxpayer money to a chat service where children are encouraged to embrace radical gender ideology by 'counselors' without consent or knowledge of their parents." Emily Hilliard, a spokesperson for the Department of Health and Human Services, said in a statement: "Continued funding of the Press 3 option threatened to put the entire 988 Suicide & Crisis Lifeline in danger of massive reductions in service." When someone calls 988, they are routed to a local crisis center if they are calling from a cellphone carrier that uses "georouting" -- a process that routes calls based on approximate areas -- unless they select one of the specialized services offered through the national network. While the Press 3 option is officially no longer part of that menu of options, which includes Spanish-language and veterans' services, states can step in to increase training for their local crisis centers or establish their own options for specialized services. California is among the states attempting to fill the new service gap, with Democratic Gov. Gavin Newsom's office announcing a partnership with The Trevor Project to provide training on LGBTQ+ youth issues for the crisis counselors in the state who answer calls to the general 988 crisis line. The state signed a $700,000 contract with the organization for the training program. The Trevor Project's Henson said the details still need to be figured out, including evaluating the training needs of California's current 988 counselors. The partnership comes as the organization's own 24/7 crisis line for LGBTQ+ youth faces a crisis of its own: The Trevor Project was one of several providers paid by the federal government to staff the Press 3 option, and the elimination of the service cut the organization's capacity significantly, according to Henson. Gordon Coombes, director of Colorado's 988 hotline, said staff there are increasing outreach to let the public know that the general 988 service hasn't gone away, even with the loss of the Press 3 option, and that its call-takers welcome calls from the LGBTQ+ population. Staff are promoting services at concerts, community events, and Rockies baseball games. Coombes said the Colorado Behavioral Health Administration contracts with Solari Crisis & Human Services to answer 988 calls, and that the training had already been equipping call-takers on the general line to support LGBTQ+ young people. The state supports the 988 services via a 7-cent annual fee on cellphone lines. Coombes said the department requested an increase in the fee to bolster its services. While the additional funds would benefit all 988 operations, the request was made in part because of the elimination of the Press 3 option, he said. Nevada plans to ensure that all 988 crisis counselors get training on working with LGBTQ+ callers, according to state health department spokesperson Daniel Vezmar. Vezmar said Nevada's $50 million investment in a new call center last November would help increase call capacity, and that the state's Division of Public and Behavioral Health would monitor the impact of the closure of the Press 3 option and make changes as needed. The Illinois Department of Human Services announced after the Press 3 option's termination that it was working to train existing call center counselors on supporting LGBTQ+ youth and promoting related affirming messages and imagery in its outreach about the 988 line. A July increase in a state telecommunications tax will help fund expanded efforts, and the agency is exploring additional financial options to fill in the new gap. Kelly Crosbie, director of North Carolina's Division of Mental Health, Developmental Disabilities and Substance Use Services, said the division has recently invested in partnerships with community organizations to increase mental health support for marginalized groups, including LGBTQ+ populations, through the state's 988 call center and other programs. "We've wanted to make sure we were beefing up the services," Crosbie said, noting that North Carolina's Republican legislature continues to restrict health care for transgender youth. Hannah Wesolowski, chief advocacy officer for the National Alliance on Mental Illness, said Congress could put the funding for the LGBTQ+ line in any final appropriations bill it passes. She also said states could individually codify permanent funding for an LGBTQ+ option, the way Washington state has created and funded a "Press 4" option for its Native American population to reach crisis counselors who are tribal members or descendants trained in cultural practices. The state created the option by carving out some of its 988 funding. No state has publicly announced a plan to make such an investment for LGBTQ+ populations. Federal lawmakers from both sides of the aisle have spoken out against the closure of the LGBTQ+ 988 option and urged that it be reinstated. At a July press conference alongside Democratic colleagues, Rep. Mike Lawler, a Republican who represents part of New York's Hudson Valley, said he and Republican Rep. Young Kim of Orange County, California, wrote to Health and Human Services Secretary Robert F. Kennedy Jr., urging him to reverse course and keep the LGBTQ+ line. "What we must agree on is that when a child is in crisis -- when they are alone, when they are afraid, when they are unsure of where to turn to, when they are contemplating suicide — they need access to help right away," Lawler said. "Regardless of where you stand on these issues, as Americans, as people, we must all agree there is purpose and worth to each and every life." If you or someone you know is struggling with thoughts of suicide -- free, confidential help is available 24 hours a day, 7 days a week. Call or text the national lifeline at 988.